Agency for the Evaluation of Medicinal Products: budget and finances, access to documents (amend. Regulation (EEC) No 2309/93)

PURPOSE : to bring the constituent instruments of the European Communities decentralised bodies into line with the New Financial Regulation of June 2002 as well as with the Regulation relating to the access to public documents of May 2001. LEGISLATIVE ACT : Council Regulation 1647/2003/EC amending Regulation 2309/93/EEC laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the evaluation of Medicinal Products. CONTENT : this Regulation aims to amend Regulation 2309/93/EC as regards the budgetary and financial rules applicable to the Agency, in order to bring it into line with the new general Financial Regulation that entered into force on 1 January 2003, and also as regards access to the Agency's documents, with a view to implementing within the Agency Regulation 1049/2001/EC of the European Parliament and of the Council of 30 May 2001 regarding access to European Parliament, Council and Commission documents. ENTRY INTO FORCE : 01/10/2003.�